Coq and Azithromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coq (coenzyme q - 10) and Azithromycin (azithromycin). Common drug interactions include breast cancer among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Coq and Azithromycin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,465 Coq users. Check the latest studies of Coq.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.



On Jul, 29, 2026

53 people who take Coq and Azithromycin together, and have interactions are studied.

Coq and Azithromycin drug interactions.

What are the common drug interactions of Coq and Azithromycin, by gender? *:

female:

  1. Breast cancer
  2. Breast cancer metastatic
  3. Cervix haemorrhage uterine (bleeding from cervix in birth canal)
  4. Disability
  5. Epicondylitis (tennis elbow)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Herpes zoster
  8. Hypertension (high blood pressure)
  9. Injury
  10. Intervertebral disc degeneration (spinal disc degeneration)

male:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Abdominal pain upper
  4. Agitation (state of anxiety or nervous excitement)
  5. Anaemia (lack of blood)
  6. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Asthenia (weakness)
  9. Ataxia (loss of full control of bodily movements)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the common drug interactions of Coq and Azithromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac disorder
  2. Dyspepsia (indigestion)
  3. Fatigue (feeling of tiredness)
  4. Gallbladder disorder
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Pain
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Cholecystitis chronic (long lasting infection of gallbladder)

40-49:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Depression
  3. Drug effect decreased
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Headache (pain in head)
  6. Intestinal obstruction
  7. Joint injury
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Muscle spasms (muscle contraction)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Confusional state
  2. Decreased appetite
  3. Dehydration (dryness resulting from the removal of water)
  4. Dizziness
  5. Dysstasia (difficulty in standing)
  6. Fatigue (feeling of tiredness)
  7. Feeling hot
  8. Gait disturbance
  9. Gout (uric acid crystals building up in the body)
  10. Lethargy (tiredness)

60+:

  1. Ankle fracture
  2. Intervertebral disc degeneration (spinal disc degeneration)
  3. Breast cancer metastatic
  4. Cervix haemorrhage uterine (bleeding from cervix in birth canal)
  5. Disability
  6. Epicondylitis (tennis elbow)
  7. Herpes zoster
  8. Hypertension (high blood pressure)
  9. Injury
  10. Intervertebral disc protrusion (spinal disc protrusion)

What are the existing conditions these people have? *

  1. High Blood Pressure: 14 people, 26.42%
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood): 10 people, 18.87%
  3. Anaemia (lack of blood): 10 people, 18.87%
  4. Immunodeficiency Common Variable: 8 people, 15.09%
  5. Pain: 7 people, 13.21%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.55%
  7. Depression: 4 people, 7.55%
  8. Multiple Myeloma (cancer of the plasma cells): 3 people, 5.66%
  9. Multiple Allergies (allergy to multiple agents): 3 people, 5.66%
  10. Infection: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Coq and Azithromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coq and Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 and azithromycin (the active ingredients of Coq and Azithromycin, respectively), and Coq and Azithromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: